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Abstract
Background: The Surviving Sepsis Campaign (SSC) guidelines for the management of severe sepsis (SS) and septic shock
(SSh) have been recommended to reduce morbidity and mortality.
Materials and Methods: A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to
optimize SS and SSh shock patients’ clinical outcomes were performed by applying sepsis bundles (6- and 24-hour) in May
2006. We compared bundle compliance and patient outcomes before (July 2005-April 2006) and after (May 2006-December
2009) implementation of the interventions.
Results: A total of 564 SS and SSh patients were identified. Prior to the intervention, compliance with the 6 hour-sepsis
resuscitation bundle was only 6%. After the intervention, compliance was as follows: 8.2% from May to December 2006,
9.3% in 2007, 21.1% in 2008 and 13.7% in 2009. For the 24 hour-management bundle, baseline compliance was 15.0%. After
the intervention, compliance was 15.1% from May to December 2006, 21.4% in 2007, 27.8% in 2008 and 44.4% in 2009. The
in-hospital mortality was 54.0% from July 2005 to April 2006, 41.1% from May to December 2006, 39.3% in 2007, 41.4% in
2008 and 16.2% in 2009.
Conclusion: These results suggest reducing SS and SSh patient mortality is a complex process that involves multiple
performance measures and interventions.
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Introduction
Severe sepsis and septic shock are the major causes of
admission and death in intensive care units (ICUs). The sepsis
syndromes are lethal and expensive conditions, with hospital
mortality rates for severe sepsis ranging between 30% and 50%
[1,2]. In the United States, this results in an estimated 751,000
cases and 215,000 deaths annually [1]. In Brazil, the incidence
density is 57 per 1,000 patient-days and the mortality rate of
patients with severe sepsis and septic shock is 47.3% and 52.2%,
respectively [3].
In 2004, the Surviving Sepsis Campaign (SSC) introduced
guidelines for the management of severe sepsis and septic shock, as
well as strategies for bedside implementation [4,5]. The treatment
recommendations were organized in two bundles: a resuscita-
tion bundle (6 tasks to begin immediately and to be accompli-
shed within 6 hours) and a management bundle (4 tasks to be
completed within 24 hours). The 6-hour resuscitation bundle
includes the lactate determination, early cultures and antibiotic
therapy as soon as possible, and ‘‘early goal directed therapy’’
(EGDT) [2]. The first 24-hour management bundle includes
optimization of glycemic control, respiratory inspiratory plateau
pressure, and determination of the need for corticosteroids and
drotrecogin alfa (activated). EGDT is simply a protocol derived
from components that have long been recommended as standard
care for the septic patient to optimize hemodynamics. Of note, we
did not use packed red blood cells as a resuscitation fluid nor did
we use dobutamine as a standard of care for all septic shock
patients.
The aims of this study were to determine the rate of compliance
with 6-hour and 24-hour sepsis bundles, and to determine the
impact of compliance on hospital mortality in patients with severe
sepsis and septic shock.
Methods
This study was conducted in the ICU of a tertiary care, private
hospital in Sa˜o Paulo, Brazil. This open model ICU is a 38-bed
medical-surgical unit where approximately 2,200 patients are
admitted each year.
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This was a prospective quasi-experimental, before and after
study, comparing time periods before (July 2005 – April 2006)
and after (May 2006 – December 2009) implementation of
the interventions. An educational program based on the SSC
guidelines was implemented in April 2006. We have developed
lectures, e-learnings and protocols. After that sepsis bundles were
applied for severe sepsis and septic shock patients in our hospital.
This education program is reinforced each year through the
Continuing Medical Education (CME) in our hospital. The sepsis
program is addressed to the healthcare workers where are
discussed the social impact of sepsis, the diagnostic and therapeutic
interventions, the quality indicators and the process of data
collection.
Patients over 18 years old with severe sepsis and septic shock
were included in the study. This study was a quality improvement
study that was approved by Institutional Review Board (IRB) from
Hospital Israelita Albert Einstein. The requirements for informed
consent was waived by our IRB in accordance of the Code of
Federal Regulations and of the Privacy Rule.
The data collected included age, sex, admission date, the time
when severe sepsis or septic shock was diagnosed, location
before ICU admission, hospital and ICU length of stay, organ
dysfunction at the time of diagnosis, APACHE II score, and
outcome status. As per the SSC ‘‘time zero’’ was defined as the
time of diagnosis of severe sepsis and septic shock diagnosis.
Once a patient meets the bundle initiation criteria, the 6-hour
bundle is initiated by collecting serum lactate and obtaining blood
cultures before antibiotic administration. From the time of severe
sepsis (time zero), broad-spectrum antibiotic are to be adminis-
tered within 1 hour. Hypotension and/or elevated lactate are
treated with IV fluids; in the event of persistent hypotension
despite fluid resuscitation (septic shock) and/or lactate .4 mmol/
L (.36 mg/dL), maintaining adequate central venous pressure
and central venous oxygen saturation are indicated. Patients who
do not have septic shock and elevated lactate .4 mmol/L
(.36 mg/dL) do not require measurement of central venous
pressure and central venous oxygen saturation.
The 24-hour sepsis bundle for patients with severe sepsis or
septic shock includes low-dose steroids for septic shock, adminis-
tration of recombinant activated protein C (drotrecogin alfa),
maintaining glucose control $70 but ,150 mg/dL and main-
taining median inspiratory plateau pressure (IPP) ,30 cm H2O
for mechanically ventilated patients. Hydrocortisone 300 mg/day
for 7 days in 3 divided doses was administered to patients with
refractory hypotension despite adequate fluid replacement and
vasopressors. Activated protein C was indicated for patients with
$2 sepsis-induced organ failures, or APACHE II score $25 and
no contraindications.
The American College of Chest Physicians/Society of Critical
Care Medicine (ACCP/SCCM) definitions were used for clinical
conditions [6]. Sepsis was defined as infection plus two or more of
the following SIRS criteria: T.38uC or ,36uC; HR.90/min;
RR.20 breaths/min (or Paco2,32 mm Hg); or WBC count,
.12,000 cells/mL or ,4,000 cells/mL (or .10% band forms).
Severe sepsis was defined as sepsis plus organ dysfunction,
hypotension, or hypoperfusion abnormalities, including lactic aci-
dosis, oliguria, or encephalopathy. Septic shock was defined as
sepsis-induced hypotension (ie, systolic BP, ,90 mm Hg or a drop
of .40 mm Hg in the absence of other cause of hypotension) plus
hypoperfusion abnormalities despite adequate fluid resuscitation.
Our hospital has an electronic system for activating a team
dedicated to diagnosing and treating severe sepsis and septic shock
patients immediately. The ICU doctor and the managing nurse
are simultaneously notified. The development of this sepsis team
(ICU doctor and managing nurse) was part of implementing the
sepsis bundle. Our hospital has also a rapid response team (named
in our hospital as ‘‘code yellow’’) since 2007. The ‘‘code yellow’’ is
a new service for emergent and urgent calls. When the patient
shows signs of acute alteration in their health, the code yellow is
activated based on the following criteria: respiratory problems
such as acute decrease in oxygen saturation ,90% and change in
respiratory frequency to ,8/minute or .28/minute; circulatory
problems: decrease in systolic arterial pressure to ,90 mmHg
associated with symptoms and change in heart rate to,40 bpm or
.130 bpm; neurologic problems: decreasing consciousness levels
and convulsions; or a serious concern with the patient’s overall
condition (patient claims to be feeling unwell or has the sensation
‘‘something is not right’’) and change in color, diaphoresis and
coolness of the patient’s extremities.
Statistical analysis
For continuous variables, mean values were compared using
two sample t-tests for independent samples. Differences in
proportions were compared using a Chi-square test or Fishers
exact test when appropriate. Mean values are reported 61 SD. All
tests of significance are two-tailed. When collinearity was identified
between two variables, the one with the greatest clinical relevance
associated with mortality was included in the multivariate analysis.
Odds ratios were calculated for independent variables associated
with in-hospital mortality in severe sepsis and septic shock patients.
The association of independent variables was expressed as odds
ratios with 95% confidence intervals. Alpha was set at 0.05. All
statistical analyses were done using the Statistical Package for the
Social Sciences software (SPSS 17.0, Chicago, IL, USA).
Results
During the study period, a total of 564 severe sepsis and septic
shock patients were identified. Patients included in this study had a
mean 6 standard deviation (SD) age of 66618.7 years; fifty-seven
percent were male. The mean6SD APACHE II score was
2367.2. The organ dysfunctions at the time of diagnosis were
76.6% with cardiac dysfunction, 51.1% with respiratory dysfunc-
tion, 48.6% with renal dysfunction, 32.6% neurologic dysfunction,
28.5% with hematologic dysfunction and 10.1% with liver
dysfunction. The mean6SD arterial lactate was 32629.9 mg/
dL. The mean6SD total fluid resuscitation was 2,09361,163 mL.
Septic shock and severe sepsis were present in 75.7% and 24.3%,
respectively. The main source of infection was 54.6% pneu-
monia, 20.2% intra-abdominal infection and 14.9% urinary tract
infection. The hospital setting where severe sepsis and septic shock
were identified was 40.9% in emergency department, 21.6% in a
medical ward, 21.5% in ICU, 9.8% in a step-down unit, 3.7% at
another hospital and 2.5% in operating room. In Table 1 we
divided patients in three groups, those who met the 6-hour bundle
compliance (n = 69, 12.2%), those who met the 24-hour bundle
compliance (but not 6-hour) (n = 124, 22.0%), and those who did
not meet measure compliance for any bundle (n = 371; 65.8%).
Bundle compliance performance
As seen in Table 2, baseline compliance with the 6-hour bundle
was only 6%. After the intervention, compliance rates were 8.2%
from May to December 2006, 9.3% in 2007, 21.1% in 2008 and
13.7% in 2009. For the 24-hour management bundle, compliance
was 15.0% at baseline, 15.1% from May to December 2006,
21.4% in 2007, 27.8% in 2008 and 44.4% in 2009. The
distribution of diagnoses was as follows: from July 2005 to April
2006 12% were severe sepsis and 88% septic shock; from May to
Sepsis Bundle Decreasing Mortality
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December 2006 15.1% were severe sepsis and 84.9% septic shock;
in 2007, 22.7% were severe sepsis and 77.3% septic shock; in
2008, 24.8% were severe sepsis and 75.2% septic shock; and in
2009 41.9% were severe sepsis and 58.1% septic shock.
Analyzing the resuscitation bundle (first 6 hours), the only 2
processes that showed compliance more than 65% were lactate
determination and use of fluids plus vasopressors to avoid
hypotension. Blood cultures collected prior to antibiotic adminis-
tration improved in the last two years, 74.4% and 72.6% of
compliance respectively. Regarding the management bundle (first
24 hours), the only 2 processes that showed compliance more than
65% were corticosteroids and inspiratory plateau pressure. The in-
hospital mortality rates were 54.0% from July 2005 to April 2006,
41.1% from May to December 2006, 39.3% in 2007, 41.4% in
2008 and 16.2% in 2009 (Table 2). Figure 1 shows the proportion
of patients with severe sepsis and septic shock who died and who
had completed the bundle measures during the study period.
6-hour and 24-hour bundle compliance associated with
mortality benefit
Univariate comparisons of mortality in severe sepsis and septic
shock patients receiving the 6-hour and 24-hour sepsis bundle,
and considering age, APACHE II and organ dysfunctions
were performed as seen in Table 3. Variables that were statisti-
cally significant in univariate analyses were selected for multiple
logistic regression. In this model, there was a statistically
significant decreased odds ratio for mortality in patients who
had received corticosteroids (OR 0.47; CI95 0.29–0.78,
Table 1. Demographic and clinical characteristics of severe sepsis and septic shock patients.
Compliance 6 h bundle
Compliance 24 h
bundle (but not 6 h) No compliance any bundle
n % n % n %
Total 69 12.2 124 22.0 371 65.8
Age (years), mean (±SD) 63619.7 65619.7 68618.0
Male 42 60.9 69 55.6 210 56.6
Arterial lactate (mg/dL), mean (±SD) 27624.5 28623.2 34629.7
Apache II, mean (±SD) 2267.0 2065.9 2467.4
Organ dysfunction
Liver 2 2.9 10 8.1 45 12.1
Cardiologic 49 71.0 82 66.1 301 81.1
Renal 27 39.1 41 33.1 207 55.8
Hematologic 10 14.5 26 21.0 125 33.7
Respiratory 40 58.0 63 50.8 185 49.9
Neurologic 25 36.2 24 19.4 135 36.4
Source of infection
Pneumonia 39 56.5 58 46.8 211 56.9
Intra-abdominal 15 21.7 25 20.2 74 19.9
Urinary 11 15.9 20 16.1 53 14.3
Skin/soft tissue 3 4.3 10 8.1 9 2.4
Endocarditis 0 0.0 2 1.6 6 1.6
Bloodstream infection 0 0.0 2 1.6 9 2.4
Others infections 1 1.4 7 5.6 9 2.4
Fluids total (ml), mean (±SD) 226961239 233361374 197161046
Previous antimicrobial therapy 36 52.2 38 30.6 131 35.3
Severe sepsis 37 53.6 50 40.3 50 13.5
Septic shock 32 46.4 74 59.7 321 86.5
Length of stay ICU (days), mean (±SD) 306141.4 9611.3 16662.7
Length of stay hospital (days), mean (±SD) 37681.8 38668.4 516122.6
Unit
Surgical room 2 2.9 4 3.2 8 2.2
Medical ward 17 24.6 22 17.7 83 22.4
Others hospital 3 4.3 4 3.2 14 3.8
Emergency department 34 49.3 66 53.2 131 35.3
Step-down unit 6 8.7 11 8.9 38 10.2
ICU 7 10.1 17 13.7 97 26.1
SD - Standard Deviation.
doi:10.1371/journal.pone.0026790.t001
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p= 0.003), and IPP,30 cmH2O for mechanically ventilated
patients (OR 0.51; CI95 0.26–0.99, p = 0.047) in the 24-hour
bundle.
There was also a statistically significant ratio for mortality
in older patients (OR 1.02; CI95 1.01–1.03, p = 0.005), a higher
APACHE II score (OR 1.05; CI95 1.02–1.08, p = 0.002), liver
dysfunction (OR 3.37; CI95 1.76–6.44, p,0.001), renal dysfunc-
tion (OR 1.97; CI95 1.32–2.96, p= 0.001), and hematologic
dysfunction (OR 2.19; CI95 1.40–3.41, p = 0.001).
A statistically significant decreased odds ratio for mortality in
patients was observed when there was complete compliance with
the 6-hour bundle (OR 0.54; CI95 0.30–0.96, p= 0.033) and when
there was complete compliance with all the indicated components of
the 24-hour bundle (OR 0.37; CI95 0.24–0.58, p,0.001).
Discussion
This study demonstrates that implementing a sepsis bundle
improved the outcomes of patients with severe sepsis and septic
Table 2. Performance of bundle compliance.
Study phases Before protocol After protocol
Period Jul/05-Apr/06 May/06-Dec/06 2007 2008 2009
Total patients = 564 N=100 (%) N=73 (%) N=140 (%) N=134 (%) N=117 (%)
Severe sepsis 12 (12.0) 11 (15.1) 32 (22.9) 33 (24.8) 49 (41.9)
Septic shock 88 (88.0) 62 (84.9) 108 (77.1) 100 (75.2) 68 (58.1)
Serum arterial lactate 72 (72.0) 68 (93.2) 121 (86.4) 123 (92.5) 96 (82.1)
Blood cultures prior to antibiotic administration 44 (44.0) 42 (57.5) 67 (47.9) 99 (74.4) 85 (72.6)
Broad-spectrum antibiotic within 1 hr 58 (58.0) 46 (63) 105 (75) 103 (77.4) 73 (62.4)
CVP.8 mmHg 60 (60.0) 44(60.3) 85 (60.7) 90 (67.7) 76 (65.0)
ScvO2 $70% 50 (50.0) 34 (46.6) 60 (42.9) 64 (48.1) 66 (56.4)
Treat hypotension (fluids plus vasopressors) 96 (96.0) 59 (80.8) 131 (93.6) 115 (86.5) 93 (79.5)
6-hour bundle all-or-none compliance 6 (6.0) 6 (8.2) 13 (9.3) 28 (21.1) 16 (13.7)
Median crystalloid or equivalent delivered (mL) 1667 2021 1955 2396 2401
Corticosteroids 76 (76.0) 65 (89) 84 (60.0) 112 (84.2) 117 (100)
Activated protein C administered in eligible patients 40 (40.0) 36 (49.3) 63 (45.0) 118 (88.7) 114 (97.4)
Glucose control.70#150 mg/dL 48 (48.0) 33 (45.2) 78 (55.7) 49 (36.8) 54 (46.2)
IPP,30 cmH2O for mechanically ventilated patients 82 (82.0) 61 (83.6) 134 (95.7) 122 (91.7) 110 (94.0)
24-hour bundle all-or-none compliance 15 (15.0) 11 (15.1) 30 (21.4) 37 (27.8) 52 (44.4)
Mortality rate 54 (54.0) 30 (41.1) 55 (39.3) 55 (41.4) 19 (16.2)
CVP – Central venous pressure.
ScvO2 - Central venous oxygen saturation.
IPP – Inspiratory Plateau Pressure.
doi:10.1371/journal.pone.0026790.t002
Figure 1. Proportion of patients with severe sepsis and septic shock who died and who had completed bundle measures during the
study period.
doi:10.1371/journal.pone.0026790.g001
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shock. [7]. At the beginning of the study, it was not easy to
convince physicians that it is necessary to apply these simple
measures and our compliance was not more than fifty percent for
the 24-hour bundle.
Something needed to be done since our mortality rates for
severe sepsis and septic shock were extremely high. Our hospital is
engaged in a patient safety program that is a resource from the
IHI. The implementation of a sepsis response team available
across the hospital allowed healthcare workers to call the sepsis
team (based in the ICU) for all suspected sepsis cases. In addition,
the implementation of the rapid response team contributed to
decreasing our mortality rates from 52% in 2005 to 16% in 2009.
Our study differs from the other studies that applied the sepsis
bundles only in the emergency department as a quality indicator
set to modify physician behavior related to the early management
of severe sepsis and septic shock [8,9,10,11]. Similar to the others
we implemented the sepsis bundle not only in the emergency
department, but also in medical and surgical wards. All ICU
patients were actively screened daily for the presence of severe
sepsis or septic shock [12,13,14]. The implementation of the
Surviving Sepsis Campaign guidelines was associated with a
significant decrease in mortality. In using these guidelines no extra
staff were allocated, but we assigned an ICU doctor and an ICU
nurse to be responsible for the sepsis bundle process during their
ICU duty.
Even though the sepsis bundles showed a real benefit for
decreasing mortality from severe sepsis and septic shock, there is a
considerable gap between the science and its application [15]. A
long period often exists between initial experimental results and
their transformation into new technologies in health. From bench
to bedside there is a difficult translation from clinical trial into
practice corroborated by the low sepsis bundle compliance
demonstrated in other studies [8,13,14]. Our data are similar to
these studies with a lower compliance to the bundle sepsis (,50%
of compliance in the 6-, 24-hour sepsis bundle). We believe that
the barriers faced to the sepsis bundle compliance are similar in
other protocols (also considering the learning curve of sepsis
knowledge for all HCWs in our ICU).
Our data did not show what are the most important
interventions with impact on mortality in the 6-hour bundle. We
do not have data about antimicrobial therapy adequacy because it
is not a component of the Surviving Sepsis Campaign. Although
there is a requirement for early antibiotic administration, there is
no requirement for early administration of appropriate anti-
microbials. Many studies have demonstrated that inadequate
antibiotic therapy is related to an increase in the mortality rate
[16,17,18]. Considering the achievement of SVO2.70%, an
Australasian multicenter study [10] had an ICU and overall in-
hospital mortality of 18.8% and 23.1% without including SVO2-
directed resuscitation in the sepsis bundle protocol. On the other
hand, another multicenter study showed that the only intervention
from the sepsis bundle with impact on mortality was the
achievement of SVO2.70% [13].
In our study, patients who had received corticosteroids (OR
0.47; CI95 0.29–0.78, p= 0.003), and IPP,30 cmH2O for
mechanically ventilated patients (OR 0.51; CI95 0.26–0.99,
p = 0.047) in the 24-hour bundle compliance had a better
outcome. It is important to mention that activated protein C
Table 3. Risk factors associated with death in severe sepsis and septic shock patients.
Variables Cases (564) Univariate analysis Multivariate analysis
Death Survival OR (CI95) p OR (CI95) p
N (%) N (%)
213 (100) 351 (100)
Age (years), mean (6SD) 69(618.2) 65(618.8) 24.04 [(27.19) – (2.089)] 0.012 1.02 (1.01–1.03) 0.005
Apache II, mean (6SD) 25(67.2) 22(66.9) 23.47 [(24.68) – (22.26)] ,0.001 1.05 (1.02–1.08) 0.002
Liver dysfunction 37 (17.4) 20 (5.7) 3.47 (1.96–6.18) ,0.001 3.37 (1.76–6.44) ,0.001
Cardiologic dysfunction 181 (85.0) 251 (71.7) 2.23 (1.43–3.47) ,0.001 1.46 (0.89–2.45) 0.15
Renal dysfunction 136 (63.8) 139 (39.7) 2.68 (1.89–3.81) ,0.001 1.97 (1.32–2.96) 0.001
Hematologic dysfunction 90 (42.3) 71 (20.3) 2.88 (1.97–4.19) ,0.001 2.19 (1.40–3.41) 0.001
Respiratory dsyfunction 115 (54.0) 173 (49.4) 1.20 (0.85–1.69) 0.29
Neurologic dysfunction 84 (39.4) 100 (28.6) 1.63 (1.14–2.33) 0.008 1.33 (0.88–2.02) 0.18
Serum arterial lactate 182 (85.4) 298 (84.9) 1.04 (0.65–1.69) 0.86
Blood cultures prior to antibiotic administration 105 (49.3) 232 (66.1) 0.49 (0.35–0.70) ,0.001 0.69 (0.46–1.03) 0.07
Broad-spectrum antibiotic within 1 hr 149 (70) 236 (67.2) 1.13 (0.78–1.64) 0.50
CVP.8 mmHg 131 (62.9) 224 (63.8) 0.91 (0.64–1.29) 0.58
ScvO2 $70% 88 (41.3) 186 (53) 0.62 (0.44–0.88) 0.007 0.78 (0.52–1.16) 0.22
Treatment of hypotension (fluids plus vasopressors) 190 (89.2) 304 (86.6) 1.27 (0.75–2.17) 0.365
Corticosteroids 149 (70) 305 (86.9) 0.35 (0.30–0.54) 0.003 0.47 (0.29–0.78) 0.003
Activated protein C administered in eligible patients 108 (50.7) 263 (74.9) 0.35 (0.24–0.50) ,0.001 0.92 (0.58–1.48) 0.74
Glucose control .70 but #150 89 (41.8) 173 (49.3) 0.74 (0.52–1.04) 0.083
IPP,30 cmH2O for mechanically ventilated patient 181 (85) 328 (93.4) 0.40 (0.22–0.70) ,0.001 0.51 (0.26–0.99) 0.047
CVP – Central venous pressure.
ScvO2 - Central venous oxygen saturation.
IPP – Inspiratory Plateau Pressure.
doi:10.1371/journal.pone.0026790.t003
Sepsis Bundle Decreasing Mortality
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e26790
was not associated with a lower mortality in our patients and in
2009 only two patients met criteria for receiving activated protein
C (APACHE II score $25, $2 sepsis-induced organ failure and
no contraindications), thus 113 patients in 2009 had no indications
for receiving activated protein C. This brings into question of the
role of activated protein C. Over the course of the study the
proportion of study patients with septic shock decreased from 88%
to 58%. We believe that the implementation of the sepsis bundle
prompted the ICU team to identify more patients with early sepsis
and to implement a more specific treatment.
There are several limitations to this study. This is not a
randomized trial but a quasi-experimental, interrupted time series
study. Quasi-experimental study designs are frequently used when
it is not logistically feasible to conduct a controlled trial. Thus,
other unmeasured factors might have occurred coincident with the
interventions that occurred since May 2006 (implementation of
the sepsis bundle), resulting in a decrease in severe sepsis and septic
shock mortality in our hospital. Finally, because this intervention
was performed at a single medical center, these results may not be
generalizable to other hospitals. Despite the limitations, our study
has broadened support for the concept that severe sepsis and septic
shock patients require multiple performance measures and quality
improvement efforts to improve outcomes. The process and
outcome measures for septic patients presented here are derived
from published guidelines and other relevant literature.
We believe that the fall in mortality is attributed to the better
care of the sepsis patient by applying the sepsis bundle and to
identify the sepsis patients. Since 2007 our hospital has been
engaged in zero tolerance for healthcare associated infections. We
have observed a significant reduction in ventilator-associated
pneumonia and in central venous associated bloodstream
infections [19,20]. We have also during the study period
implementing other ICU best practices, including glycemic control
protocol [21]. We adopt an intermediate glucose control, because
we believe that a tight glucose control is difficult to accomplish in
routine intensive care unit settings and is associated with a
significant increase in the incidence of hypoglycaemia [21,22].
However it is interesting to note that 41% of our patients included
in the study are from the emergency department; this affirms our
belief that the sepsis bundle needs to be considered as the
intervention decreasing mortality in septic shock and severe sepsis
because of the better care and the prompt recognition of these
patients in the emergency room.
In conclusion, the sepsis bundle is a quality improvement
program that should be implemented in all hospital settings, and
efforts should be made to improve bundle compliance. Further
understanding of the importance of the components of the bundle
is needed to determine which components can be changed or
replaced.
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